PRESS DIGEST-Financial Times - Jan 21

Reuters01-21

PRESS DIGEST-Financial Times - Jan 21

Jan 21 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.

Headlines

Three Ireland owner in talks over sale to Liberty Global

GSK to buy U.S. biotech behind food allergy drug for $2.2 billion

Renault to team up with French defence group to make drones for Ukraine

Independent to take over operations of London's Standard

Overview

CK Hutchison 0001.HK is in talks to sell its Irish mobile operator to Liberty Global LBTYA.O as the Hong Kong-based conglomerate continues to offload its European telecoms businesses.

GSK GSK.L has agreed to acquire Rapt Therapeutics RAPT.O, a US-based biotech whose leading drug combats food allergies, in a deal that values the company at $2.2 billion.

Renault RENA.PA has reached a deal with a French defence company Turgis Gaillard to make drones for Ukraine, in a move backed by France's defence ministry to support Kyiv against Russian aggression.

The UK's Independent Media is in advanced talks to take over the digital and commercial operations of loss making London newspaper The Standard.

(Compiled by Bengaluru newsroom)

((globalnewsmonitoring@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2605121732?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-21 11:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2605121732","market":"nz","top_or_hot":-1,"title":"PRESS DIGEST-Financial Times - Jan 21","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>PRESS DIGEST-Financial Times - Jan 21</title></head><body><p><span>Jan 21 (Reuters)</span><span> - </span>The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.</p><p>Headlines</p><p>Three Ireland owner in talks over sale to Liberty Global</p><p>GSK to buy U.S. biotech behind food allergy drug for $2.2 billion</p><p>Renault to team up with French defence group to make drones for Ukraine</p><p>Independent to take over operations of London's Standard</p><p>Overview</p><p><a href=\"https://laohu8.com/S/CKHUF\">CK Hutchison</a> <span>0001.HK</span> is in talks to sell its Irish mobile operator to Liberty Global <span>LBTYA.O</span> as the Hong Kong-based conglomerate continues to offload its European telecoms businesses. </p><p>GSK <span>GSK.L</span> has agreed to acquire Rapt <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> <span>RAPT.O</span>, a US-based biotech whose leading drug combats food allergies, in a deal that values the company at $2.2 billion.</p><p>Renault <span>RENA.PA</span> has reached a deal with a French defence company Turgis Gaillard to make drones for Ukraine, in a move backed by France's defence ministry to support Kyiv against Russian aggression. </p><p>The UK's Independent Media is in advanced talks to take over the digital and commercial operations of loss making London newspaper The Standard. </p><p> (Compiled by Bengaluru newsroom)</p><p> ((globalnewsmonitoring@thomsonreuters.com))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>PRESS DIGEST-Financial Times - Jan 21</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPRESS DIGEST-Financial Times - Jan 21\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-01-21 11:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>PRESS DIGEST-Financial Times - Jan 21</title></head><body><p><span>Jan 21 (Reuters)</span><span> - </span>The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.</p><p>Headlines</p><p>Three Ireland owner in talks over sale to Liberty Global</p><p>GSK to buy U.S. biotech behind food allergy drug for $2.2 billion</p><p>Renault to team up with French defence group to make drones for Ukraine</p><p>Independent to take over operations of London's Standard</p><p>Overview</p><p><a href=\"https://laohu8.com/S/CKHUF\">CK Hutchison</a> <span>0001.HK</span> is in talks to sell its Irish mobile operator to Liberty Global <span>LBTYA.O</span> as the Hong Kong-based conglomerate continues to offload its European telecoms businesses. </p><p>GSK <span>GSK.L</span> has agreed to acquire Rapt <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> <span>RAPT.O</span>, a US-based biotech whose leading drug combats food allergies, in a deal that values the company at $2.2 billion.</p><p>Renault <span>RENA.PA</span> has reached a deal with a French defence company Turgis Gaillard to make drones for Ukraine, in a move backed by France's defence ministry to support Kyiv against Russian aggression. </p><p>The UK's Independent Media is in advanced talks to take over the digital and commercial operations of loss making London newspaper The Standard. </p><p> (Compiled by Bengaluru newsroom)</p><p> ((globalnewsmonitoring@thomsonreuters.com))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0306806265.USD","symbol_name":"SCHRODER ISF GLOBAL DIVIDEND MAXIMISER \"A\" ACC","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nL4N3YM08A:1","article_id":"2605121732","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2605121732","pubTimestamp":1768965124,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"PRESS DIGEST-Financial Times - Jan 21Jan 21 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.Headlines","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0306806265.USD":"SCHRODER ISF GLOBAL DIVIDEND MAXIMISER \"A\" ACC","BK1230":"工业集团企业","LU0971552673.USD":"Allianz European Equity Dividend Cl AM DIS H2-USD","LU0225771236.USD":"SCHRODER ISF GLOBAL EQUITY YIELD \"A\" (USD) INC MF","LU1035777561.USD":"AB SICAV I - EUROPEAN EQUITY PORTFOLIO \"A\" (USDHDG) ACC","LBTYA":"自由全球","IE00B3T34201.USD":"BNY MELLON GLOBAL EQUITY INCOME \"B\" (USD) INC","BK1601":"香港本地股","LU1098665638.USD":"FRANKLIN MUTUAL EUROPEAN \"A\" (USDHDG) H1 ACC","LU1400636657.SGD":"Allianz Europe Income and Growth Cl AMg DIS H2-SGD","IE00BQJZX424.USD":"FRANKLIN MV EUROPEAN EQUITY GROWTH AND INCOME \"A\" (USDHDG) INC","LU1228905037.USD":"NINETY ONE GSF GLOBAL QUALITY DIVIDEND GROWTH \"A\" (USD) ACC","BK4139":"生物科技","IE00BWDBJ516.SGD":"Legg Mason QS - MV European Equity Growth and Income A Mdis SGD-H Plus","LU0161305163.EUR":"SCHRODER ISF EUROPEAN VALUE \"A\" (EUR) ACC","LU1046248800.SGD":"Allianz European Equity Dividend Cl AM DIS H2-SGD","LU0575583348.USD":"SCHRODER ISF UK EQUITY \"A\" (USD) INC AV","LU0321505868.SGD":"Schroder ISF Global Dividend Maximiser A Dis SGD","LU1202635105.USD":"ALLIANZ EUROPE INCOME AND GROWTH \"AM\" (USDHDG) INC","LU0321505439.SGD":"Schroder ISF Global Dividend Maximiser A Acc SGD","LU1487256676.USD":"THREADNEEDLE (LUX) UK EQUITY INCOME \"ZUH\" (USDHDG) ACC","LU0203347892.USD":"SCHRODER ISF QEP GLOBAL ACTIVE VALLUE \"A\" (USD)  INC AV","LU0985481810.HKD":"SCHRODER ISF GLOBAL EQUITY YIELD \"A\" (HKD) INC M","LU1064927863.SGD":"JPMorgan Funds - Europe Dynamic A (acc) SGD-H","LU1983299246.USD":"SCHRODER ISF HEALTHCARE INNOVATION \"A\" (USD) ACC","BK1521":"挪威政府全球养老基金持仓","LU0225284248.USD":"SCHRODER ISF GLOBAL EQUITY YIELD \"A\" ACC","LU1228905540.USD":"NINETY ONE GSF GLOBAL QUALITY DIVIDEND GROWTH \"A\" (USD) INC 2","LU1670756490.USD":"ALLIANZ EUROPE INCOME AND GROWTH \"AT\" (USDHDG) ACC","LU0058720904.USD":"联博国际健康护理基金A","00001":"长和","BK5011":"制药","RAPT":"RAPT Therapeutics, Inc.","LU0109981661.USD":"FRANKLIN MUTUAL EUROPEAN \"A\" (USD) ACC","LU1400636574.HKD":"ALLIANZ EUROPE INCOME AND GROWTH \"AMG\" (HKDHDG) INC","LU1302929846.USD":"ALLIANZ EUROPEAN EQUITY DIVIDEND \"AMG\" (USDHDG) INC","IE0034235071.USD":"PINEBRIDGE EUROPE RESEARCH ENHANCED EQUITY \"A\" (USD) ACC","IE0032431581.USD":"PINEBRIDGE GREATER CHINA EQUITY \"A\" (USD) ACC","LU1048588211.SGD":"Blackrock Asian Dragon A2 SGD-H","BK1500":"做空集合股","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","GSK.UK":"葛兰素史克","BK1569":"长和系","LU0211331839.USD":"FRANKLIN MUTUAL GLB DISCOVERY \"A\" (USD) ACC","LU0072462343.USD":"贝莱德亚洲巨龙基金","LU0545562505.USD":"NINETY ONE GSF GLOBAL QUALITY DIVIDEND GROWTH \"A\" (USD) INC","LU0971552830.HKD":"ALLIANZ EUROPEAN EQUITY DIVIDEND \"AM\" (HKDHDG) INC","BK4089":"非传统电信运营商","LU1015430645.USD":"SCHRODER ISF UK EQUITY \"A\" (USDHDG) ACC","LU1645745479.HKD":"ALLIANZ EUROPE INCOME AND GROWTH \"AM\" (HKDHDG) INC"},"translate_title":"新闻摘要-金融时报-1月21日","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LBTYA":0.9,"RAPT":0.9,"GSK.UK":0.9,"00001":0.9},"content_text":"PRESS DIGEST-Financial Times - Jan 21Jan 21 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.HeadlinesThree Ireland owner in talks over sale to Liberty GlobalGSK to buy U.S. biotech behind food allergy drug for $2.2 billionRenault to team up with French defence group to make drones for UkraineIndependent to take over operations of London's StandardOverviewCK Hutchison 0001.HK is in talks to sell its Irish mobile operator to Liberty Global LBTYA.O as the Hong Kong-based conglomerate continues to offload its European telecoms businesses. GSK GSK.L has agreed to acquire Rapt Therapeutics RAPT.O, a US-based biotech whose leading drug combats food allergies, in a deal that values the company at $2.2 billion.Renault RENA.PA has reached a deal with a French defence company Turgis Gaillard to make drones for Ukraine, in a move backed by France's defence ministry to support Kyiv against Russian aggression. The UK's Independent Media is in advanced talks to take over the digital and commercial operations of loss making London newspaper The Standard.  (Compiled by Bengaluru newsroom) ((globalnewsmonitoring@thomsonreuters.com))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2605121732","isCrawlerRequest":true}